OrbusNeich Names B. Wayne Johnson President and Chief Operating Officer and Expands Board of Directors

Hong Kong (ots/PRNewswire) -

OrbusNeich today announced the appointment of B. Wayne Johnson as
president and chief operating officer and the expansion of its board
of directors with the additions of Scott Addonizio, vice president &
general manager, Shenzhen operations; David Camp, vice president,
sales & marketing, Europe, the Middle East and Africa (EMEA); and
Christophe Lee, vice president and chief financial officer.

Mr. Johnson has more than 32 years of medical device experience,
primarily in the areas of general management, operations and product
development. He was previously senior vice president and chief
operating officer of OrbusNeich. Prior to joining OrbusNeich, he was
president and chief executive officer of Sutura Inc., a development
stage company based in Fountain Valley, Calif., focused on
commercializing suture-mediated wound closure products. Preceding
Sutura, he was president and chief executive officer of Prostec LLC
(a division of Syntheon LLC), dedicated to devices for prostate
brachytherapy. Before Prostec, he was employed by Cordis for 18
years, during which time he held various roles of increasing
responsibility, including vice president and general manager of the
company's largest facility. He was also a member of the Cordis
operating board as vice president of worldwide operations.

Since 2012 he has been a member of the board of directors of
Microvisk Technologies Ltd., a U.K.-based company developing medical
diagnostic devices. He holds a B.S. in biology and both an MBA and an
M.S. degree in management from Rensselaer Polytechnic Institute.

"Throughout their tenure with OrbusNeich, Scott, David and
Christophe have been instrumental in the growth and progress of the
company," said Mr. Johnson. "As members of the board of directors,
they will certainly provide valuable insight and perspective at this
dynamic time in the company's development as we focus on sales of the
COMBO Dual Therapy Stent(TM) and on other value creation projects in
order to maximize the return for our investors."

Mr. Addonizio has more than 19 years of medical device experience
with companies including Boston Scientific and Cordis. He joined
Orbus as a project manager and is the primary holder of the "stent
having dual helical design" patent, which is the backbone of all
OrbusNeich stent platforms. In 2005, he was appointed director &
general manager, Shenzhen operations, leading operations and product
development efforts.

Mr. Camp has more than 26 years of medical device experience,
working with companies such as Cordis and Spectranetics. He
co-founded Orbus Medical Technologies in 1996 and served as president
and chief executive officer. He was instrumental in developing and
commercializing various technologies. After the merger of Orbus and
Neich Medical in 2005, he has served in various roles, most recently
as vice president, sales and marketing for the EMEA.

Mr. Lee has more than 21 years of experience in the financial
services sector. Prior to joining OrbusNeich, he worked at FrontPoint
Partners, Sun Hung Kai Financial, Goldman Sachs and Bankers Trust.
Mr. Lee served as the Chairman of the Hong Kong Chapter of the
Alternative Investment Management Association (AIMA) from 2003-2012.
He was appointed by the HKSAR government to serve on the Advisory
Committee of the Securities and Futures Commission (SFC) from 2007 to
2009, and, since March 2013, to serve on the Financial Services
Development Council. He was also a member of the Hong Kong Trade
Development Council Financial Services Advisory Committee from 2007
to 2011.

About OrbusNeich

OrbusNeich is a global company that designs, develops,
manufactures and markets innovative medical devices for the treatment
of vascular diseases. Current products are the world's first dual
therapy stent, the COMBO Dual Therapy Stent, and the world's first
pro-healing stent, the Genous(TM) Stent. Other products include
stents and balloons marketed under the names of Azule(TM), R stent,
Scoreflex(TM), Sapphire(TM), Sapphire II and Sapphire NC. OrbusNeich
is headquartered in Hong Kong and has operations in Shenzhen, China;
Fort Lauderdale, Fla.; Hoevelaken, The Netherlands; and Tokyo, Japan.
OrbusNeich supplies medical devices to interventional cardiologists
in more than 60 countries. For more information, visit
http://www.OrbusNeich.com.

Follow OrbusNeich on Twitter at http://www.twitter.com/OrbusNeich,
and learn more about the company and its innovative technology on
OrbusNeich's YouTube Channel:
http://www.youtube.com/user/OrbusNeichMedia.

ots Originaltext: OrbusNeich
Im Internet recherchierbar: http://www.presseportal.de

Contact:
Global Media Contacts: Robert Hanvik, +44 (0) 78 7282 7715,
robert.hanvik@fleishmaneurope.com ; Iva Ng, OrbusNeich, +852
3109-7268,
ing@orbusneich.com